BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8640323)

  • 1. Educating patients about cystic fibrosis carrier screening in a primary care setting.
    Bernhardt BA; Chase GA; Faden RR; Geller G; Hofman KJ; Tambor ES; Holtzman NA
    Arch Fam Med; 1996 Jun; 5(6):336-40. PubMed ID: 8640323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teaching about cystic fibrosis carrier screening by using written and video information.
    Clayton EW; Hannig VL; Pfotenhauer JP; Parker RA; Campbell PW; Phillips JA
    Am J Hum Genet; 1995 Jul; 57(1):171-81. PubMed ID: 7611285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization.
    Tambor ES; Bernhardt BA; Chase GA; Faden RR; Geller G; Hofman KJ; Holtzman NA
    Am J Hum Genet; 1994 Oct; 55(4):626-37. PubMed ID: 7942840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of population based screening for carriers of cystic fibrosis.
    Bekker H; Denniss G; Modell M; Bobrow M; Marteau T
    J Med Genet; 1994 May; 31(5):364-8. PubMed ID: 8064812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of cystic fibrosis testing in primary care: supply push or demand pull?
    Bekker H; Modell M; Denniss G; Silver A; Mathew C; Bobrow M; Marteau T
    BMJ; 1993 Jun; 306(6892):1584-6. PubMed ID: 8329922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group.
    Axworthy D; Brock DJ; Bobrow M; Marteau TM
    Lancet; 1996 May; 347(9013):1443-6. PubMed ID: 8676627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.
    Ciske DJ; Haavisto A; Laxova A; Rock LZ; Farrell PM
    Pediatrics; 2001 Apr; 107(4):699-705. PubMed ID: 11335747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population screening for cystic fibrosis in Western Australia: community response.
    Honnor M; Zubrick SR; Walpole I; Bower C; Goldblatt J
    Am J Med Genet; 2000 Jul; 93(3):198-204. PubMed ID: 10925381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial and educational outcomes associated with home- and clinic-based pretest education and cystic fibrosis carrier testing among a population of at-risk relatives.
    Cheuvront B; Sorensen JR; Callanan NP; Stearns SC; DeVellis BM
    Am J Med Genet; 1998 Feb; 75(5):461-8. PubMed ID: 9489788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier screening for cystic fibrosis: implications for obstetric and gynecologic practice.
    Elias S; Annas GJ; Simpson JL
    Am J Obstet Gynecol; 1991 Apr; 164(4):1077-83. PubMed ID: 2014829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services.
    Henneman L; Bramsen I; van Kempen L; van Acker MB; Pals G; van der Horst HE; Adèr HJ; van der Ploeg HM; ten Kate LP
    Community Genet; 2003; 6(1):5-13. PubMed ID: 12748433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP.
    Hartley NE; Scotcher D; Harris H; Williamson P; Wallace A; Craufurd D; Harris R
    J Med Genet; 1997 Jun; 34(6):459-64. PubMed ID: 9192264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'It is not in my world': an exploration of attitudes and influences associated with cystic fibrosis carrier screening.
    McClaren BJ; Delatycki MB; Collins V; Metcalfe SA; Aitken M
    Eur J Hum Genet; 2008 Apr; 16(4):435-44. PubMed ID: 18059419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active cascade testing for carriers of cystic fibrosis gene.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do young people think about screening for cystic fibrosis?
    Cobb E; Holloway S; Elton R; Raeburn JA
    J Med Genet; 1991 May; 28(5):322-4. PubMed ID: 1865469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct marketing of cystic fibrosis carrier screening: commercial push or population need?
    Cuckle H; Lilford R; Wilson J; Sehmi I
    J Med Genet; 1995 Sep; 32(9):758. PubMed ID: 8544204
    [No Abstract]   [Full Text] [Related]  

  • 18. Involving consumers in the development of an educational program for cystic fibrosis carrier screening.
    Myers MF; Bernhardt BA; Tambor ES; Holtzman NA
    Am J Hum Genet; 1994 Apr; 54(4):719-26. PubMed ID: 8128971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for cystic fibrosis carrier state.
    Mennuti MT; Thomson E; Press N
    Obstet Gynecol; 1999 Mar; 93(3):456-61. PubMed ID: 10075000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adolescents' attitude towards carrier testing for cystic fibrosis and its relative stability over time.
    Welkenhuysen M; Evers-Kiebooms G; Decruyenaere M; Van den Berghe H; Bande-Knops J; Van Gerven V
    Eur J Hum Genet; 1996; 4(1):52-62. PubMed ID: 8800929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.